Alnylam Pharmaceuticals非GAAP每股收益16.26美元，超出预期14.01美元，营收14.6亿美元，超出预期3000万美元（ALNY:NASDAQ）
· seekingalpha.com
Alnylam Pharmaceuticals第三季度盈利因强劲营收和大幅超预期的每股收益而飙升。
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
If you have an ad-blocker enabled you may be blocked from ...